ArticleFrontiers in neurology2019

Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?

Ahmed Abdelhak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.